ARAC（PDX Pharmaceuticals Inc）

N/A

Report date: 2022/08/03 10:35:53

Base Information

Drug NameARAC（PDX Pharmaceuticals Inc）
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionProgrammed death-ligand 1 blockersPolo like kinase 1 inhibitors
TargetsProgrammed death-ligand 1Polo like kinase 1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPdx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPdx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A